eISSN: 1897-4309
ISSN: 1428-2526
Contemporary Oncology/Współczesna Onkologia
Current issue Archive Manuscripts accepted About the journal Supplements Addendum Special Issues Editorial board Abstracting and indexing Subscription Contact Instructions for authors Ethical standards and procedures
SCImago Journal & Country Rank
2/2020
vol. 24
 
Share:
Share:
more
 
 
abstract:
Original paper

The role of NEAT1 lncRNA in squamous cell carcinoma of the head and neck is still difficult to define

Joanna Kozłowska
1
,
Kinga Kozioł
1
,
Maciej Stasiak
1
,
Justyna Obacz
1
,
Kacper Guglas
2, 3
,
Paulina Poter
4, 5
,
Andrzej Mackiewicz
1, 6
,
Tomasz Kolenda
1, 6

1.
Department of Cancer Immunology, Chair of Medical Biotechnology, Poznan University of Medical Sciences, Poznan, Poland
2.
Laboratory of Cancer Genetics, Greater Poland Cancer Centre, Poznan, Poland
3.
Postgraduate School of Molecular Medicine, Medical University of Warsaw, Warsaw, Poland
4.
Department of Oncologic Pathology and Prophylaxis, Poznan University of Medical Sciences, Greater Poland Cancer Centre, Poznan, Poland
5.
Department of Pathology, Pomeranian Medical University, Szczecin, Poland
6.
Department of Diagnostics and Cancer Immunology, Greater Poland Cancer Centre, Poznan, Poland
Contemp Oncol (Pozn) 2020; 24 (2): 96-105
Online publish date: 2020/07/03
View full text
Get citation
ENW
EndNote
BIB
JabRef, Mendeley
RIS
Papers, Reference Manager, RefWorks, Zotero
AMA
APA
Chicago
Harvard
MLA
Vancouver
 
Introduction
Nuclear paraspeckle assembly transcript 1 (NEAT1) is considered an oncogene in various cancers, but the role in head and neck squamous cell carcinomas (HNSCC) is not clear.

Material and methods
Expression of NEAT1 in HNSCC patients’ samples and cell lines was analysed using qRT-PCR. The TCGA expression data of NEAT1 were analysed depending on the clinicopathological parameters and tumour localisation. Correlation and gene set enrichment analysis (GSEA) were conducted, and the results were analysed using the REACTOME and GeneMANIA tools. All statistical analyses were carried out using GraphPad Prism 5 and Statistica 13.

Results
The NEAT1 was up-regulated in some patients’ samples and HNSCC cell lines. Moreover, TCGA data analysis indicated that the expression of NEAT1 was up-regulated in tumour tissue in most of the analysed TCGA cancers, including HNSCC. There were no significant differences in levels of NEAT1 between various tumour localisations. Overall survival of individuals with high expression of NEAT1 was slightly longer than in the low-expression group (p = 0.0553). Analysis of genes that positively and negatively correlated with NEAT1 indicated that they are involved in mRNA metabolism and cellular transport. Moreover, the GSEA revealed that in patients with low NEAT1, the most up-regulated genes were in clusters associated with the cAMP-dependent pathway, the MYC pathway, unfolded protein response, the MTORC1 signalling pathway, oxidative phosphorylation, and DNA repair.

Conclusions
Patients with low expression of NEAT1 display worse overall survival, presumably due to up-regulation of certain oncogenic signalling pathways that are important for cancerogenesis.

keywords:

NEAT1, lncRNA, HNSCC, head and neck, TCGA, biomarker, suppressor

Quick links
© 2020 Termedia Sp. z o.o. All rights reserved.
Developed by Bentus.
PayU - płatności internetowe